All news (page 2)

• 

  26 August 2026

  Búzios field posts new monthly and daily gas export records

  July average exports reached 10.8 million m³/d; daily peak hit 14.1 million m³ on 6 August after CO₂-membrane upgrades and Route 3 operation.
• 

  26 August 2026

  Nobian and Air Products sign long-term offtake for RFNBO hydrogen from Rotterdam

  Long-term offtake secures certified RFNBO hydrogen from a 14,000‑t/yr renewables-powered chlor‑alkali electrolyser, supporting RED III compliance and Rotterdam hub supply.
• 

  26 August 2026

  Technip Energies wins engineering services contract from L&T for ADNOC Offshore

  Detailed engineering for new offshore facilities, upgrades and modifications on a major UAE EPCIC development; contract falls in the €50–250m "significant" band.
• 

  26 August 2026

  ORLEN starts production at Idun Nord, Alve Nord and Ørn in Skarv area

  Adds ~30 million boe (mostly gas) and >4 billion m³ of gas; tied to Skarv FPSO with 4.5 kg CO2/boe intensity; lifts Skarv output toward 9 million boe by 2027.
• 

  26 August 2026

  Asahi Kasei opens Hipore wet-process separator coating line in Charlotte, NC

  New Charlotte coating line adds regional wet-process separator capacity; commercial output planned H2 fiscal 2026 and will pair with a planned Canadian plant.
• 

  25 August 2026

  Metso to supply ~EUR 25m processing package for Yenipazar polymetallic project

  Key concentrator package for a greenfield polymetallic mine in Yozgat province covering comminution, flotation, dewatering and online analytics.

• 

  25 August 2026

  CATL unveils full-chain storage and partners with Moura for Brazil auction

  Announces local partnership to bid in Brazil's Capacity Reserve Auction and displays TENER S/H/Sodium utility portfolio plus local service, testing and parts network.
• 

  25 August 2026

  LKAB builds 25 Mt/y sorting plant in Malmberget

  New facility adds ~7–8 Mt/y capacity, prepares for apatite handling for phosphorus and rare-earth plans, backed by SEK 6bn investment and due in 2028.
• 

  25 August 2026

  Equinor reshapes international portfolio — targets 950,000 boepd outside Norway by 2030

  Portfolio concentrated into fewer countries, expected ~USD 20bn free cash flow 2026–2030; US, Brazil and Angola to drive growth; higher margins from high-grading and stepped-up exploration.
• 

  25 August 2026

  Equinor: Troll Phase 3 Stage 2 boosts gas supply to Troll A

  Stage 2 began production on 22 August, accelerating 55 billion scm from Troll West, coming online early and several hundred million NOK below the original cost estimate.
• 

  25 August 2026

  Olin and Huntsman shareholders approve all‑stock merger to form OlinHuntsman

  Transaction cleared overwhelming preliminary shareholder votes; remains subject to regulatory approvals, certification and other customary closing conditions with closing targeted H1 2027.
• 

  25 August 2026

  MAIRE awards ~€50m in STS contracts to Nextchem/Stamicarbon

  Contracts fund urea licensing, PDP and proprietary equipment across Asia, Europe and North America, plus a feasibility study for a 40,000 t/yr polyolefin upcycling plant.
• 

  25 August 2026

  Axens reaches 300th Prime-G+® unit with modular start-up at Raízen Argentina

  Modular FCC gasoline desulfurization unit commissioned in Argentina, marking the 300th Prime‑G+® installation and demonstrating faster delivery with reduced onsite activities.
• 

  25 August 2026

  Chugai files vamikibart in Japan for uveitic macular edema

  If approved, would be Japan’s first intravitreal anti‑IL‑6 therapy for uveitic macular edema; filing is supported by global Phase III MEERKAT and SANDCAT data.
• 

  25 August 2026

  EnviTec Biogas advances two French biomethane projects

  Conversion of Biowatt to biomethane and construction of Valoverte set commissioning between end‑2026 and July‑2027, using EnviThan upgrading units.
• 

  25 August 2026

  Sinopec 2026 mid-year results

  H1 revenue RMB1,436.6bn; net profit RMB25.6bn; interim dividend RMB0.105/share; oil & gas eq 263.47m bbl; ethylene 6.394m t; chemical exports up 70%.
• 

  24 August 2026

  Metso acquires Valmet's Flowrox hose and progressive cavity pump business

  Acquires peristaltic hose and progressive cavity pump tech plus aftermarket parts and services; products to be rebranded and production moved to Lappeenranta; closing Oct 1, 2026.
• 

  24 August 2026

  KBR to license PureSAF for Kazakhstan's first SAF plant

  PureSAF (alcohol-to-jet) licence and engineering for Kazakhstan's first SAF plant, integrating agricultural feedstocks to support aviation hub ambitions.
• 

  24 August 2026

  Johnson & Johnson's IMAAVY approved by FDA as first therapy for warm autoimmune hemolytic anemia

  FDA cleared therapy for wAIHA in patients ≥12 previously or currently treated with corticosteroids; showed rapid hemoglobin gains and durable responses in Phase 2/3 ENERGY.
• 

  24 August 2026

  Petrobras launches EPC tender for 5,500 m3/day HDT at Repar

  EPC tender opened for a 5,500 m3/day Diesel S-10 hydrotreating unit at Repar; part of the 2026–2030 portfolio and could help add ~70 kbpd with similar projects.
• 

  24 August 2026

  Equinor, Aker BP and Vår Energi form exploration alliance on the Norwegian continental shelf

  A joint programme will target high‑impact prospects to find standalone field candidates by testing 20–25 opportunities and drilling about five wells per year.
• 

  24 August 2026

  Uniper and Equinor sign 15‑year Norwegian gas supply deal for Germany

  15‑year contract secures over 30 TWh/year from 2027–2041 to bolster Germany's gas security and develop lower‑emissions natural gas.
• 

  24 August 2026

  Takeda’s ORZEYFUL approved in Japan for narcolepsy type 1

  Japan clears the first oral OX2R agonist to address underlying orexin deficiency for adults with narcolepsy type 1.
• 

  24 August 2026

  Sobi Japan and Asahi Kasei: Empaveli approved in Japan for C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis

  First complement inhibitor in Japan for patients aged 12+ with these rare kidney diseases; VALIANT showed 68.1% proteinuria reduction and eGFR stabilization versus placebo.
• 

  24 August 2026

  Group refining and new‑materials units implement leadership conference

  Units move to stabilise refining volumes, raise new‑materials output and upgrade product mix while pushing structural adjustment under the 'one base, two wings, three chains, four new' pattern.
• 

  24 August 2026

  AGC and Neusignal Therapeutics partner on Alzheimer candidate NTX-083

  End-to-end CDMO support for NTX-083 completed — manufacturing process established and IND CMC documentation prepared ahead of planned US clinical trials in 2026.
• 

  24 August 2026

  Statkraft and Hydro: PPA for 876 GWh/year 2031–2040

  Secures 876 GWh/year from 2031–2040 (~8.8 TWh total) with delivery in Norwegian price area NO5; follows April 2026 deals covering 2029–2038.
• 

  24 August 2026

  GSK’s Hibsago (bepirovirsen) approved in Japan as first functional cure for chronic hepatitis B

  Japan approves the first functional cure for chronic hepatitis B: 6‑month ASO therapy yields 19% functional cure in patients with HBsAg ≤3000 IU/ml; approval fast‑tracked by SENKU.
• 

  24 August 2026

  GSK’s Jemperli accepted for priority FDA review in dMMR/MSI‑H locally advanced rectal cancer

  FDA sets PDUFA Feb 2027 for Jemperli’s supplemental filing based on AZUR‑1 data showing sustained 12‑month complete responses, potentially avoiding chemo, radiation and surgery.
• 

  24 August 2026

  Sumitomo-led consortium wins JOGMEC design contract for ship-based CCS at Mizushima

  Design and feasibility work for CO2 capture, liquefaction, temporary storage and maritime shipping at Mizushima to support a 3.43 Mtpa liquefied CO2 hub.